CL3-78989-006. EYEGUARD-C study

• Research type

  Research Study

• Full title

  A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects with Non-infectious Intermediate, Posterior, or Pan- uveitis Currently Controlled with Systemic Treatment. The EYEGUARD™-C study.

• IRAS ID

  124878

• Contact name

  Carlos Pavesio

• Contact email

  carlos.pavesio@moorfields.nhs.uk

• Sponsor organisation

  XOMA (US) LLC

• Eudract number

  2012-001609-25

• ISRCTN Number

  ISRCTN

• REC name

  London - Central Research Ethics Committee

• REC reference

  13/LO/0717

• Date of REC Opinion

  31 May 2013

• REC opinion

  Favourable Opinion